Tandem Diabetes Care (TNDM) EBT (2013 - 2026)
Tandem Diabetes Care (TNDM) posted EBT of -$19.9 million for Q1 2026, down 520.9% on a QoQ basis from $4.7 million in Q4 2025, and up 83.7% year-over-year from -$10.8 million in Q1 2025.
Tandem Diabetes Care (TNDM) EBT (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's EBT history runs 14 years deep, the most recent figure standing at -$19.9 million for Q1 2026.
- Quarterly EBT rose 83.7% year-over-year to -$19.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$98.0 million (up 43.8% YoY) and the FY2025 annual result came in at -$200.3 million, down 117.99% from the prior year.
- EBT was -$19.9 million for Q1 2026 at Tandem Diabetes Care, down from $4.7 million in the prior quarter.
- Across five years, EBT topped out at $4.7 million in Q4 2025 and bottomed at -$123.6 million in Q1 2023.
- A 5-year average of -$36.8 million and a median of -$29.7 million in 2024 frame the typical range for EBT.
- Annual changes were most pronounced in 2022 — EBT plunged 916.36% — and 2025, when it jumped 29450.0%.
- Tandem Diabetes Care's EBT stood at -$16.2 million in 2022, then plunged by 93.85% to -$31.3 million in 2023, then jumped by 100.05% to $16000.0 in 2024, then soared by 29450.0% to $4.7 million in 2025, then tumbled by 520.9% to -$19.9 million in 2026.
- Business Quant data shows TNDM's EBT at -$19.9 million in Q1 2026, $4.7 million in Q4 2025, and -$25.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | -19.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.90 Mn |
| Dec 31, 2025 | 4.73 Mn |
| Sep 30, 2025 | -25.14 Mn |
| Jun 30, 2025 | -57.72 Mn |
| Mar 31, 2025 | -122.10 Mn |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | -22.61 Mn |
| Jun 30, 2024 | -29.74 Mn |
| Mar 31, 2024 | -39.53 Mn |
| Dec 31, 2023 | -31.31 Mn |
| Sep 30, 2023 | -30.73 Mn |
| Jun 30, 2023 | -34.60 Mn |
| Mar 31, 2023 | -123.60 Mn |
| Dec 31, 2022 | -16.15 Mn |
| Sep 30, 2022 | -47.35 Mn |
| Jun 30, 2022 | -12.95 Mn |
| Mar 31, 2022 | -16.44 Mn |
| Dec 31, 2021 | 11.10 Mn |
| Sep 30, 2021 | 5.80 Mn |
| Jun 30, 2021 | 4.10 Mn |